Diabetes, Heart and Cardiovascular Diseases News Chronicle Diabetes, Cardiovascular and Heart Diseases. Article 24
Published on July 13, 2016 at 9:05 AM


Benefits With Pomegranate Flowers

Pomegranate flowers contains antioxidants and photochemical reservoirs. They helps diabetes patients in lowering health complications. Not only flowers, seeds and peel too helps in lowering health complications. Previous study done during 2011 indicated that pomegranate flowers along with diabetes treatment improves brain performance in diabetes patients. Ayurveda and Unani treatments too use pomegranate flowers for the treatment of diabetes.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Risks With High BMI
2. Risks With Heart Disease

 

Benefits With Peanut Butter
Number of studies shows peanut butter restricts development of obesity and type 2 diabetes (T2D). Researchers found that BMI has reduced in the children who ate peanut based snacks and it is an healthy alternative to meat.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Study Of Butter Consumption
2. Risks With Statins Pills

 

Trials With Victoza (Liraglutide) Drug

Results of 3 year long LEADER trials on Victoza (liraglutide) manufactured by Novo Nordisk's were presented at the 76th scientific sessions of ADA. Victoza drug has reduced blood glucose levels and weight. Victoza LEADER drug trials shows 22 percent reduction in cardiovascular death (CVD), 22% lower risk for kidney disease and non-fatal stroke by 13 percent compared with placebo arm. Atherosclerosis leads an individual to heart attacks and stroke and victoza plays a role in treating it. Novo Nordisk says victoza is the only approved GLP-1 receptor agonist which reduces all major CV events vs placebo. Dr John Buse, director of the UNC Diabetes Care Center is the chairman for the LEADER steering Committee. Victoza drug is commercially available in more than 85 countries for the treatment of type 2 diabetes (T2D).

Update on Aug 8, 2017 : The Committee for Medicinal Products for Human Use (CHMP) panel, which authorize medicines in the European Union (EU), voted positively for using Victoza (liraglutide) drug, manufactured by Novo Nordisk following LEADER trial results. The CHMP positive opinion was referred to European Commission for the approval of the proposed drug indication modification on Victoza (liraglutide) label. Victoza (liraglutide) drug is the second drug to be recommended for type 2 diabetes patients (T2D) for the treatment of cardiovascular diseases. The SGLT-2 inhibitor Jardiance (empagliflozin), a type 2 diabetes (T2D) drug, was the first drug to include cardiovascular risk reduction on its label in the European Union.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Study Of Liraglutide Drug On Heart Failure
2. Device To Release Drugs In Eye
3. Benefits With Alcohol Free Blueberry Blackberry Wine

 

Benefits With Jardiance Drug
EMPA-REG OUTCOME trial was conducted by the lead investigator Dr Bernard Zinman, director of the Diabetes Center at the Mount Sinai Hospital. In type 2 diabetes (T2D) individuals, cardiovascular events risks increases with age. EMPA-REG OUTCOME trial results indicates jardiance (empagliflozin) reduces risk of CV death and hospitalization with heart failure in all age groups. The results were showing effectiveness of jardiance and study results were presented in the American Diabetes Association (ADA) 76th Scientific Sessions in New Orleans.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Approval Of Jardiance
2. Device To Predict Diabetes
3. Benefits With Coffee Consumption

 

Treatment With Darapladib Drug

Part of the retina in the eye to read fine details is called macula. Swelling of macula happens due to high levels of sugar present in the blood vessels. This is the most common problem with diabetes patients and 7% of the diabetes patients suffer with this problem. The common treatment for this problem is injection of a drug directly into eye every 4 to 6 weeks. This treatment is very expensive and only 50% of the patients may get relief. But Professor Alan Stitt (Queen's University) and Dr Patric Turowski (UCL Institute of Ophthalmology) in collaboration with GlaxoSmithKline found that Darapladib (in tablet form) has the potential to reduce the vision loss to wider group of patients with diabetes. Now researchers are planning for clinical trial with darapladib drug for alternative treatment to diabetic related blindness.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Risks With Fine Dust
2. Risks To Heart Attack And Diabetes Before Menopause

 

Benefits With Vegetarian Diet
Harvard University researchers studied food habits and health records of 200,000 health professionals in the US for the past 20 years and concluded that

Author of the study was Ambika Satija and co-author of the study was Prof Frank Hu. Findings were published in the journal PLoS Medicine and research was funded by U.S. National Institutes of Health.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Benefits With Mediterranean Diet
2. SR10171 Drug For The Treatment Of Bone Disease And Diabetes
3. Risks With Heart Attack

 

Benefits With Invokana (Canagliflozin)
Random phase 2 study of Invokana (canagliflozin) drug made by Janssen (subsidiary of Johnson & Johnson) indicates that invokana drug has lowered mean glucose levels and glycemic variability in type 1 diabetes (T1D) mellitus patients. Amount of time spent within target glucose range too increased. But the results shows increased risk to ketoacidosis. Lack of insulin causes body to produce excess blood acids and is called ketoacidosis. Ketoacidosis leads to severe kidney injury and US FDA warns risks associated with Invokana drug.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Trials With Invokana
2. Study Of eGFR Trajectory

 

Benefits With Mediterranean Diet
Study by Dr Ramon Estruch of the University of Barcelona indicates that nuts and olive oil in Mediterranean diet prevents weight gain and may even reduce body weight. Study results were published in the Lancet Diabetes and Endocrinology.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Benefits With Vegan Diet
2. Risks With Early Or Late Menopause

 

Usability Study Of OneTouch Via Patch
According to the data presented during ADA conference in New Orleans, diabetes patients using OneTouch via patch missed fewer insulin dosages and felt less stress and embarrassment compared with multiple daily insulin injections. With the new OneTouch Via patch on demand insulin delivery system, diabetes patients can receive insulin whenever / wherever required by pressing two buttons on the device. The system is water resistant and can be used for 3 days.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Study With Metformin Drug In Preventing Preterm Birth

 

Benefits With Weight Loss During Pregnancy

Gestational diabetes (GD) effects mother during pregnancy. The born baby can be abnormally large babies (known as macrosomia) with high blood glucose levels. Obesity can amplify gestational diabetes issues. But how the born baby's health is affected if the obese mother loose weight during the pregnancy? Researchers examined 614 pregnant obese women with gestational diabetes with average age of 31 years. 151 women lost weight after the diagnosis of gestational diabetes (GD) and 463 women gained weight. The results showed that

Research findings were presented at the 76th Scientific Sessions of ADA in New Orleans, Louisiana.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Risks With Low Birth Weight
2. Risks With Diabetes During Pregnancy
3. Risks To Diabetes Induced Cognitive Impairment

 

Partnership Between Canary Health And Medtronic
Canary Health is a Los Angeles based company that provides chronic health management software. Now Canary Health partnered with Medtronic and Medtronic became reseller and distributor for Canary Health products. They are planning to develop additional solutions based on Medtronic's and Canary Health product range.

       
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and past the code below):

Also related to this story
1. Devices From Medtronic
2. Risks With Adrenal Tumors NFATs
3. About Coronary Heart Disease (CHD)

 

Categories

Sitemap 1   Sitemap 2   Sitemap 3   Sitemap 4

 

Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.


Published by Jammi Vasista, Chennai, India.
Email Jammi[no-space]Vasista1991[at]gmail[dot]com
Phone 91-944-578-3182.
Address Diabetes News Chronicle, No 40, Kaveri Street, Rajaji Nagar, Villivakkam, Chennai, India. Pin : 600049.